Results 241 to 250 of about 2,846,954 (287)

Targeting the EpCAM‐AXL axis to overcome drug resistance in lung cancer

open access: yesMolecular Oncology, EarlyView.
Lung cancer cells often evade therapy by hijacking signaling pathways. We reveal that cleaved EpCAM (sEpCAM) stabilizes the oncogenic protein AXL, driving NF‐κB and STAT3‐mediated chemoresistance. This EpCAM‐AXL axis identifies a high‐risk patient subset with poor prognosis.
Alexa Guerrero‐Alba   +5 more
wiley   +1 more source

Peat Pellets as Enrichment Material for Weaned Piglets. [PDF]

open access: yesAnimals (Basel)
Middelkoop A   +4 more
europepmc   +1 more source

Characterization of therapeutic antibodies targeting lymphatic and vascular resistance factor for the treatment of hypervascularized and highly metastatic cancers

open access: yesMolecular Oncology, EarlyView.
LVRF (lymphatic and vascular resistance factor) is a VEGFA splice variant upregulated in response to anti‐angiogenic therapy that fosters tumor adaptation through enhanced vascularization, lymphangiogenesis, and metastatic dissemination. Targeting LVRF with fully human neutralizing antibodies disrupts these processes and limits resistant tumor growth ...
Marion David   +12 more
wiley   +1 more source

Contagion and escalation of rule violations. [PDF]

open access: yesProc Biol Sci
Molleman L   +4 more
europepmc   +1 more source

Context-dependent effects of whole-body vibration on reproductive function and penile tissue integrity in sedentary male rats. [PDF]

open access: yesExp Physiol
Ayva M   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy